CD44 and breast carcinoma: To investigate tumor cell heterogeneity during tumor progression, we first examined the expression of reported breast CSC markers Cd24, Cd44, Cd61, Sca1, and Cd49f (38) in the RNA-Seq data set from Ross et al. (39) encompassing several murine breast cancer models.